The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Re-evaluating the neutrophil-to-lymphocyte ratio: Machine learning-based variable selection for predicting survival at twelve months in late-stage cancer patients receiving immunotherapy.
 
Daniel Spakowicz
No Relationships to Disclose
 
Mingjia Li
No Relationships to Disclose
 
Rebecca Hoyd
No Relationships to Disclose
 
Jarred Thomas Burkart
No Relationships to Disclose
 
Sandip H. Patel
No Relationships to Disclose
 
Marium Husain
No Relationships to Disclose
 
Kai He
Honoraria - Geneplus
Consulting or Advisory Role - Perthera
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Mirati Therapeutics (Inst)
 
Carolyn J Presley
No Relationships to Disclose
 
Erin Marie Bertino
Consulting or Advisory Role - Boehringer Ingelheim; Takeda
 
Peter G. Shields
No Relationships to Disclose
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Nexus Pharmaceuticals Inc
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Biothera; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Helsinn Therapeutics; Incyte; Inivata; Loxo; Merck; Novartis; Peregrine Pharmaceuticals; Pfizer; Synta; Synta
Research Funding - Bristol-Myers Squibb
 
Hiral A. Shah
No Relationships to Disclose
 
Gabriel Tinoco
No Relationships to Disclose
 
Edmund Folefac
No Relationships to Disclose
 
Priyanka Bhateja
No Relationships to Disclose
 
Claire F. Verschraegen
No Relationships to Disclose
 
Gregory Alan Otterson
Consulting or Advisory Role - Novartis (Inst); Novocure (Inst); Takeda (Inst)
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Ignyta (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Lang Li
No Relationships to Disclose
 
Kari Lynn Kendra
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Dwight Hall Owen
Consulting or Advisory Role - AstraZeneca; L&M Policy Research
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Palobiofarma (Inst)
Travel, Accommodations, Expenses - AstraZeneca